SCHEMBL2861394

SCHEMBL2861394

CCc1c(O)cc(O)c(C(=O)c2ccc(O)cc2)c1CC(=O)OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 9/20 0.40
HSP90AB1 P08238 1/20 0.40
EYA3 Q99504 2/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA7 P43166 2/20 0.39
CA9 Q16790 2/20 0.39
CA14 Q9ULX7 2/20 0.39
EGFR P00533 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
GFER P55789 1/20 0.38
ESRRB O95718 1/20 0.37
ESR1 P03372 2/20 0.37
ESR2 Q92731 2/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2865471 0.90 CYP3A4 (0.45) SLC22A12CA1CA2ALDH1A1GAA
SCHEMBL2861760 0.90 GAA (0.44) HSP90AB1CA12CA9ALDH1A1GAA
SCHEMBL2863503 0.89 L3MBTL1 (0.40) HSP90AB1CA12CA9EGFRALDH1A1
SCHEMBL2865023 0.86 AKR1C3 (0.44) ALDH1A1MAPTHTT
SCHEMBL2861252 0.86 SMN1; SMN2 (0.38) HSP90AB1CA12CA1CA2CA7
SCHEMBL2860161 0.85 CYP1A2 (0.50) CA12CA1CA2CA7CA9
SCHEMBL2856141 0.85 VNN1 (0.38) ALDH1A1GAAGFER
SCHEMBL2860145 0.85 TUBB4A (0.48) SLC22A12ALDH1A1GAALMNAHTT
SCHEMBL2867456 0.85 SLC22A12 (0.42) SLC22A12EYA3CA2ESR1ESR2
SCHEMBL2861691 0.84 SMN1; SMN2 (0.42) HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1642880-B1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KIRIN CO LTD (JP) 2013-09-04 EP disclosed
US-7767693-B2 Hsp90 family protein inhibitors KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-08-03 US disclosed
CN-100567242-C Hsp90 family protein blockers KYOWA HAKKO KOGYO KK (JP) 2009-12-09 CN disclosed
US-20090247522-A1 Hsp90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-10-01 US disclosed
US-7538224-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070032532-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-02-08 US disclosed
CN-1791568-A Hsp90 family protein inhibitors KYOWA HAKKO KOGYO KK (JP) 2006-06-21 CN disclosed
EP-1642880-A1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-04-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032532-A1 Hsp90 family protein inhibitors HSP90AB1, HSP90B1, HSP90AB2P SLC22A12 1461/4885HSP90AB1 1/4885EYA3 3825/4885
US-20090247522-A1 Hsp90 FAMILY PROTEIN INHIBITORS HSP90AB1, HSP90B1, HSP90AB2P SLC22A12 1461/4885HSP90AB1 1/4885EYA3 3825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.